Edition:
United States

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

9,790.00ZAc
24 May 2019
Change (% chg)

-157.00 (-1.58%)
Prev Close
9,947.00
Open
10,004.00
Day's High
10,031.00
Day's Low
9,785.00
Volume
1,410,772
Avg. Vol
1,818,400
52-wk High
29,800.00
52-wk Low
6,899.00

About

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business... (more)

Overall

Beta: 0.56
Market Cap(Mil.): R139,674.20
Shares Outstanding(Mil.): 456.45
Dividend: 287.00
Yield (%): 0.94

Financials

  APNJ.J Industry Sector
P/E (TTM): 27.38 29.30 32.55
EPS (TTM): 11.17 -- --
ROI: 6.19 14.23 13.82
ROE: 11.92 15.46 15.24

Deals of the day-Mergers and acquisitions

May 20 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

May 20 2019

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

May 20 2019

UPDATE 1-South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

May 20 2019

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy Aspen's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

May 20 2019

UPDATE 1-South Africa's rand recovers after U.S. jobs data, stocks slide on Aspen

JOHANNESBURG, March 8 South Africa's rand firmed on Friday, recovering from a nine-week low after sluggish U.S. employment data pushed the dollar lower and saw demand for emerging markets return.

Mar 08 2019

UPDATE 2-Shares in S.Africa's Aspen plunge on debt, slow sale proceeds

* Debt levels still within creditor threshold (Adds historical debt, details)

Mar 08 2019

Aspen shares plunged by nearly 40 pct on debt worries

JOHANNESBURG, March 8 Shares of South Africa-based drugmaker Aspen Pharmacare plunged nearly 40 percent on Friday, as rising debt worried investors.

Mar 08 2019

UPDATE 1-Aspen to split South African pharma business after disposal of non-core assets

JOHANNESBURG, March 7 Multinational drugmaker Aspen Pharmacare said it will split its South African Commercial Pharmaceuticals business into two divisions as it disposes of non-core assets to reduce its debt.

Mar 07 2019

UPDATE 1-Aspen Pharmacare drops on debt worries and revenue forecast

JOHANNESBURG, Dec 14 Shares in Aspen Pharmacare fell more than 8 percent on Friday, a day after the South African drugmaker said it had negotiated a temporary relaxation of its lending agreements and forecast little growth in full-year revenues.

Dec 14 2018

South Africa's Aspen strikes distribution deal with U.S. drugmaker Mylan

JOHANNESBURG Aspen Pharmacare has struck a deal with U.S. generics maker Mylan to distribute a portfolio of prescription and over-the-counter drugs in Australia and New Zealand.

Dec 13 2018

Earnings vs. Estimates